Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 15 results.
User Information
Export Records
  1. 1.   Interaction of diazonamide a with tubulin
  2. Bai,Ruoli; Cruz-Monserrate, Zobeida; Fenical, William; Pettit, George R; Hamel,Ernest
  3. Archives of biochemistry and biophysics. 2020, FEB 15; 680: 108217.
  1. 3.   Interactions of Halichondrin B and Eribulin with Tubulin
  2. Bai, R. L.; Nguyen, T. L.; Burnett, J. C.; Atasoylu, O.; Munro, M. H. G.; Pettit, G. R.; Smith, A. B.; Gussio, R.; Hamel, E.
  3. Journal of Chemical Information and Modeling. 2011, Jun; 51(6): 1393-1404.
  1. 4.   Bombesin marine toxin conjugates inhibit the growth of lung cancer cells
  2. Moody, T. W.; Pradhan, T.; Mantey, S. A.; Jensen, R. T.; Dyba, M.; Moody, D.; Tarasova, N. I.; Michejda, C. J.
  3. Life Sciences. 2008 82(15-16): 855-861.
  1. 5.   Dolastatin 11 conformations, analogues and pharmacophore
  2. Ali, M. A.; Bates, R. B.; Crane, Z. D.; Dicus, C. W.; Gramme, M. R.; Hamel, E.; Marcischak, J.; Martinez, D. S.; McClure, K. J.; Nakkiew, P.; Pettit, G. R.; Stessman, C. C.; Sufi, B. A.; Yarick, G. V.
  3. Bioorganic & Medicinal Chemistry. 2005, JUL 1; 13(13): 4138-4152.
  1. 6.   A quantitative evaluation of the effects of inhibitors of tubulin assembly on polymerization induced by discodermolide, epothilone B, and paclitaxel
  2. Dabydeen, D. A.; Florence, G. J.; Paterson, I.; Hamel, E.
  3. Cancer Chemotherapy and Pharmacology. 2004 53(5): 397-403.
  1. 7.   Gymnangiamide, a cytotoxic pentapeptide from the marine hydroid Gymnangium regae
  2. Milanowski, D. J.; Gustafson, K. R.; Rashid, M. A.; Pannell, L. K.; McMahon, J. B.; Boyd, M. R.
  3. Journal of Organic Chemistry. 2004 69(9): 3036-3042.
  1. 8.   Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel-Dreyer chromatography
  2. Cruz-Monserrate, Z.; Mullaney, J. T.; Harran, P. G.; Pettit, G. R.; Hamel, E.
  3. European Journal of Biochemistry. 2003 270(18): 3822-3828.
  1. 9.   Diazonamide A and a synthetic structural analog: Disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulin
  2. Cruz-Monserrate, Z.; Vervoort, H. C.; Bai, R. L.; Newman, D. J.; Howell, S. B.; Los, G.; Mullaney, J. T.; Williams, M. D.; Pettit, G. R.; Fenical, W.; Hamel, E.
  3. Molecular Pharmacology. 2003 63(6): 1273-1280.
  1. 10.   Lyngbyastatin 1 and Ibu-epilyngbyastatin 1: Synthesis, stereochemistry, and NMR line broadening
  2. Bai, R. L.; Bates, R. B.; Hamel, E.; Moore, R. E.; Nakkiew, P.; Pettit, G. R.; Sufi, B. A.
  3. Journal of Natural Products. 2002 65(12): 1824-1829.
  1. 11.   Synthesis and biological evaluation of aryl azide derivatives of combretastatin A-4 as molecular probes for tubulin
  2. Pinney, K. G.; Mejia, M. P.; Villalobos, V. M.; Rosenquist, B. E.; Pettit, G. R.; Verdier-Pinard, P.; Hamel, E.
  3. Bioorganic & Medicinal Chemistry. 2000 8(10): 2417-2425.
  1. 12.   Cytotoxic and tubulin-interactive hemiasterlins from Auletta sp and Siphonochalina spp. sponges
  2. Gamble, W. R.; Durso, N. A.; Fuller, R. W.; Westergaard, C. K.; Johnson, T. R.; Sackett, D. L.; Hamel, E.; Cardellina, J. H.; Boyd, M. R.
  3. Bioorganic & Medicinal Chemistry. 1999 7(8): 1611-1615.
  1. 13.   Antineoplastic Agents 360 - Synthesis and Cancer Cell Growth Inhibitory Studies of Dolastatin 15 Structural Modifications
  2. Pettit, G. R.; Flahive, E. J.; Boyd, M. R.; Bai, R. L.; Hamel, E.; Pettit, R. K.; Schmidt, J. M.
  3. Anti-Cancer Drug Design. 1998 13(1): 47-66.
  1. 14.   Structure-Activity Requirements For Flavone Cytotoxicity and Binding to Tubulin
  2. Beutler, J. A.; Hamel, E.; Vlietinck, A. J.; Haemers, A.; Rajan, P.; Roitman, J. N.; Cardellina, J. H.; Boyd, M. R.
  3. Journal of Medicinal Chemistry. 1998 41(13): 2333-2338.
  1. 15.   Antineoplastic Agents 365 - Dolastatin 10 Sar Probes
  2. Pettit, G. R.; Srirangam, J. K.; Barkoczy, J.; Williams, M. D.; Boyd, M. R.; Hamel, E.; Pettit, R. K.; Hogan, F.; Bai, R. L.; Chapuis, J. C.; McAllister, S. C.; Schmidt, J. M.
  3. Anti-Cancer Drug Design. 1998 13(4): 243-277.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel